Drug diluent and efficacy of methylene blue in septic shock: authors' reply
- PMID: 37670332
- PMCID: PMC10481601
- DOI: 10.1186/s13054-023-04633-0
Drug diluent and efficacy of methylene blue in septic shock: authors' reply
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Comment on
-
Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial.Crit Care. 2023 Mar 13;27(1):110. doi: 10.1186/s13054-023-04397-7. Crit Care. 2023. PMID: 36915146 Free PMC article. Clinical Trial.
References
-
- ProvayBlue® (methylene blue) injection, 0.5%, USP—Potential Medication Errors Associated with Improper Preparation. https://americanregent.com/media/2116/np-pb-us-0019_hcp-letter-preparati.... Accessed 24 Oct 2023.
-
- Safety Wires—Don’t dilute ProvayBlue in normal Saline. ISMP Nurse Advise ERR. Volume 15, Issue 5, May 2017. https://www.ismp.org/sites/default/files/attachments/2018-03/NurseAdvise.... Accessed 24 Oct 2023.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
